UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 309

Sortiert nach

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

Nature communications, 2017-08, Vol.8 (1), p.268-11, Article 268

2017

Link zum Volltext

Verfügbarkeit prüfen

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma

Leukemia, 2019-07, Vol.33 (7), p.1713-1722

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical value of molecular subtyping multiple myeloma using gene expression profiling

Leukemia, 2016-02, Vol.30 (2), p.423-430

2016

Link zum Volltext

Verfügbarkeit prüfen

Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols

Leukemia, 2012-11, Vol.26 (11), p.2398-2405

2012

Link zum Volltext

Verfügbarkeit prüfen

Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma

Leukemia, 2017-03, Vol.31 (3), p.637-644

2017

Link zum Volltext

Verfügbarkeit prüfen

VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myeloma

Leukemia, 2008-07, Vol.22 (7), p.1419-1427

2008

Link zum Volltext

Verfügbarkeit prüfen

Clinical feasibility of TBI with helical tomotherapy

Bone marrow transplantation (Basingstoke), 2011-07, Vol.46 (7), p.929-935

2011

Link zum Volltext

Verfügbarkeit prüfen

Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant

Bone marrow transplantation (Basingstoke), 2004-04, Vol.33 (8), p.823-828

2004

Link zum Volltext

Verfügbarkeit prüfen

Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model

Bone marrow transplantation (Basingstoke), 2006-10, Vol.38 (7), p.501-506

2006

Link zum Volltext

Verfügbarkeit prüfen

Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients

Bone marrow transplantation (Basingstoke), 2006-05, Vol.37 (9), p.857-864

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of pomalidomide in high-risk relapsed and refractory multiple myeloma

Leukemia, 2014-12, Vol.28 (12), p.2413-2415

2014

Link zum Volltext

Verfügbarkeit prüfen

Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients

Bone marrow transplantation (Basingstoke), 2004-02, Vol.33 (4), p.389-396

2004

Link zum Volltext

Verfügbarkeit prüfen

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

Haematologica (Roma), 2012-11, Vol.97 (11), p.1761-1767

2012

Link zum Volltext

Verfügbarkeit prüfen

G-CSF plus plerixafor (Mozobil) to mobilize hematopoietic stem cells in patients with thrombocytopenia or leukopenia prior to auto-SCT

Bone marrow transplantation (Basingstoke), 2013-02, Vol.48 (2), p.303-304

2013

Link zum Volltext

Verfügbarkeit prüfen

Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Blood cancer journal (New York), 2016-07, Vol.6 (7), p.e453-e453

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia

Blood, 2000, Vol.95 (1), p.67-71

2000

Link zum Volltext

Verfügbarkeit prüfen

Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma

The New England journal of medicine, 2006-03, Vol.354 (10), p.1021-1030

2006

Link zum Volltext

Verfügbarkeit prüfen

The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma

Leukemia, 2015-08, Vol.29 (8), p.1713-1720

2015

Link zum Volltext

Verfügbarkeit prüfen

Inhibiting MEK in MAPK pathway-activated myeloma

Leukemia, 2016-04, Vol.30 (4), p.976-980

2016

Link zum Volltext

Verfügbarkeit prüfen

Making progress in treating multiple myeloma with total therapies: issue of complete remission and more

Leukemia, 2008-08, Vol.22 (8), p.1633-1636

2008

Link zum Volltext

Verfügbarkeit prüfen

Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome

Bone marrow transplantation (Basingstoke), 2001-11, Vol.28 (9), p.873-878

2001

Link zum Volltext

Verfügbarkeit prüfen

Cardiac complications in relapsed and refractory multiple myeloma patients treated with carfilzomib

Blood cancer journal (New York), 2015-01, Vol.5 (1), p.e272-e272

2015

Link zum Volltext

Verfügbarkeit prüfen

Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma

Leukemia, 2015-05, Vol.29 (5), p.1195-1201

2015

Link zum Volltext

Verfügbarkeit prüfen

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma

Leukemia, 2014-12, Vol.28 (12), p.2410-2413

2014

Link zum Volltext

Verfügbarkeit prüfen

P1140: TIME TO TUMOR, SYMPTOMATIC AND LABORATORY RESPONSES FOLLOWING SILTUXIMAB TREATMENT IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE

HemaSphere, 2022-06, Vol.6 (Suppl), p.1030-1031

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 309

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(293)
Mit Volltextzugriff
(286)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(169)
Life Sciences & Biomedicine
(146)
Humans
(141)
Hematology
(89)
Biological And Medical Sciences
(85)
Medical Sciences
(80)
Male
(72)
Female
(68)
Oncology
(60)
Middle Aged
(58)
Adult
(53)
Immunology
(39)
Aged
(35)
Multiple Myeloma
(34)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(33)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(33)
Transplantation
(30)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(29)
Bone Marrow
(28)
Stem Cell Transplantation
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Bone Marrow Transplantation
(32)
Blood
(28)
Journal Of Clinical Oncology
(28)
Leukemia
(16)
British Journal Of Haematology
(15)
Neophilologus
(13)
Amsterdamer Beiträge Zur Älteren Germanistik
(10)
Blood Cancer Journal
(8)
Cytotherapy
(5)
Experimental Hematology
(5)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma

Clinical value of molecular subtyping multiple myeloma using gene expression profiling

Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols

Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma

VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myeloma

Clinical feasibility of TBI with helical tomotherapy

Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant

Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model

Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients

Phase II study of pomalidomide in high-risk relapsed and refractory multiple myeloma

Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients

Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents

G-CSF plus plerixafor (Mozobil) to mobilize hematopoietic stem cells in patients with thrombocytopenia or leukopenia prior to auto-SCT

Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma

Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia

Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma

The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma

Inhibiting MEK in MAPK pathway-activated myeloma

Making progress in treating multiple myeloma with total therapies: issue of complete remission and more

Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome

Cardiac complications in relapsed and refractory multiple myeloma patients treated with carfilzomib

Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma

P1140: TIME TO TUMOR, SYMPTOMATIC AND LABORATORY RESPONSES FOLLOWING SILTUXIMAB TREATMENT IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE

Suchergebnisse filtern